Principle Health Systems Acquires Telos PGX: A Strategic Move to Advance Personalized Healthcare
Principle Health Systems Acquires Telos PGX: A Strategic Move to Advance Personalized Healthcare
D.J. Hart will continue to play a pivotal role in the organization as he joins the leadership team at Principle Health Systems as the Director of Pharmacogenetic Operations. His deep understanding of the challenges faced by SNFs and his commitment to driving positive change will be instrumental in shaping the future of personalized medicine.ADDISON, Texas, Dec. 9, 2024 /PRNewswire/ -- Principle Health Systems, the leading mobile diagnostic provider for the long-term care community, is excited to announce its acquisition of Telos PGX, a pioneering force in pharmacogenetic testing. This strategic move will further accelerate Telos PGX's mission to revolutionize healthcare by providing personalized medication solutions.
德克薩斯州艾迪森，2024年12月9日 /PRNewswire/ -- Principle Health Systems，作爲長期護理社區領先的移動診斷提供商，很高興地宣佈收購Telos PGX，這是一家在藥物基因測試領域的先鋒力量。這一戰略舉措將進一步加速Telos PGX的使命，即通過提供個性化的用藥解決方案來徹底改變醫療保健。
Telos PGX has rapidly gained recognition for its proprietary Telos PGX Program, specifically designed to support Skilled Nursing Facilities (SNFs) and enhance patient care.
By leveraging advanced pharmacogenetic testing, Telos PGX empowers healthcare providers to make precise medication decisions, reducing adverse drug reactions and optimizing treatment plans.
Telos PGX因其專有的Telos PGX計劃而迅速獲得認可，該計劃專爲支持專業護理機構（SNFs）而設計，旨在提升患者護理。
通過利用先進的藥物基因測試，Telos PGX使醫療保健提供者能夠做出準確的用藥決策，減少不良藥物反應並優化治療方案。
"We are thrilled to join forces with Principle Health Systems," said D.J. Hart, Founder and CEO of Telos PGX. "This transaction will provide us with the resources and expertise to scale our operations, accelerate innovation, and expand our reach. Together, we will transform the future of healthcare and improve the lives of countless patients."
「我們很高興與Principle Health Systems攜手合作，」Telos PGX的創始人兼首席執行官D.J. Hart說道。「這一交易將爲我們提供擴展業務、加速創新和擴大影響力所需的資源和專業知識。我們將一起改變醫療保健的未來，提高無數患者的生活質量。」
D.J. Hart will continue to play a pivotal role in the organization as he joins the leadership team at Principle Health Systems as the Director of Pharmacogenetic Operations. His deep understanding of the challenges faced by SNFs and his commitment to driving positive change will be instrumental in shaping the future of personalized medicine.
D.J. Hart將繼續在組織中發揮關鍵作用，他將作爲藥物基因操作董事加入Principle Health Systems的領導團隊。他對專業護理機構面臨的挑戰深刻理解，以及他推動積極變革的承諾，將對塑造個性化醫學的未來起到重要作用。
"Telos PGX's innovative approach to pharmacogenetic testing aligns perfectly with our vision to deliver advanced healthcare solutions," said James Dieter, CEO at Principle Health Systems. "By combining Principle's experience and resources with Telos's innovation, we will be able to accelerate the adoption of personalized medicine and improve patient outcomes."
「Telos PGX在藥物基因測試方面的創新方法與我們提供先進醫療解決方案的願景完全一致，」Principle Health Systems的首席執行官James Dieter說道。「通過將Principle的經驗和資源與Telos的創新結合，我們將能夠加速個性化醫學的採用，改善患者結果。」
About Telos PGX:
Telos PGX is a leading provider of pharmacogenetic testing solutions in the LTC market. By analyzing an individual's genetic makeup, Telos PGX empowers healthcare providers to make informed medication decisions, improving patient outcomes and reducing healthcare costs.
關於Telos PGX：
Telos PGX是長期護理市場領先的藥物基因測試解決方案提供商。通過分析個人的基因組成，Telos PGX使醫療保健提供者能夠做出明智的用藥決策，提高患者結果並降低醫療成本。
About Principle Health Systems:
Principle Health Systems is a healthcare innovation leader committed to improving patient outcomes and enhancing the quality of care. Through strategic partnerships and advanced technology, Principle Health Systems is transforming the healthcare landscape to help patients age in place.
關於原則健康系統：
原則健康系統是一家醫療創新領袖，致力於改善患者的結果和提升護理質量。通過戰略合作伙伴關係和愛文思控股科技，原則健康系統正在轉變醫療格局，幫助患者在家中安享晚年。
SOURCE Principle Health Systems
來源：原則健康系統
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想讓貴公司的資訊在PRNEWSWIRE.COM上特色展示嗎？
譯文內容由第三人軟體翻譯。